Tech Company Financing Transactions

BioStable Funding Round

BioStable, operating out of Austin, received $625 thousand from TriStar Technology Fund.

Transaction Overview

Company Name
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$625,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2621 Ridgepoint Dr. 100
Austin, TX 78754
USA
Email Address
Overview
BioStable develops innovative new products for the treatment of cardiovascular diseases.
Profile
BioStable LinkedIn Company Profile
Social Media
BioStable Company Twitter Account
Company News
BioStable News
Facebook
BioStable on Facebook
YouTube
BioStable on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Wheeler
  John Wheeler LinkedIn Profile  John Wheeler Twitter Account  John Wheeler News  John Wheeler on Facebook
VP - Bus. Development
Thomas Williamson
  Thomas Williamson LinkedIn Profile  Thomas Williamson Twitter Account  Thomas Williamson News  Thomas Williamson on Facebook
VP - Operations
Julie Thomas
  Julie Thomas LinkedIn Profile  Julie Thomas Twitter Account  Julie Thomas News  Julie Thomas on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2012: Vendscreen venture capital transaction
Next: 12/31/2012: Crimson Hexagon venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary